PE20070590A1 - PROCESO PARA LA SINTESIS DE COMPUESTOS 3-HIDROXI-7,8,9,10-TETRAHIDROBENZO[h]QUINOLIN-4-CARBOXILICO SUSTITUIDOS COMO INHIBIDORES DE SELECTINA - Google Patents
PROCESO PARA LA SINTESIS DE COMPUESTOS 3-HIDROXI-7,8,9,10-TETRAHIDROBENZO[h]QUINOLIN-4-CARBOXILICO SUSTITUIDOS COMO INHIBIDORES DE SELECTINAInfo
- Publication number
- PE20070590A1 PE20070590A1 PE2006001208A PE2006001208A PE20070590A1 PE 20070590 A1 PE20070590 A1 PE 20070590A1 PE 2006001208 A PE2006001208 A PE 2006001208A PE 2006001208 A PE2006001208 A PE 2006001208A PE 20070590 A1 PE20070590 A1 PE 20070590A1
- Authority
- PE
- Peru
- Prior art keywords
- tetrahidrobenzo
- quinolin
- hydroxy
- synthesis
- compounds substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/10—Aza-phenanthrenes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE A PROCESOS DE PREPARACION DE COMPUESTOS 3-HIDROXI-7,8,9,10-TETRAHIDROBENZO[h]QUINOLIN-4-CARBOXILICO SUSTITUIDOS DE FORMULA (VI) EN DONDE R1 ES INDEPENDIENTEMENTE H, HALOGENO, OH, CN, ENTRE OTROS; R2 ES H, HALOGENO, OH, CN, ALQUILO(C1-C6) ENTRE OTROS; R3 INDEPENDIENTEMENTE H, HALOGENO, ENTRE OTROS; p Y q SON INDEPENDIENTEMENTE 1, 2 O 3. TAL COMO ACIDO 2-(4-CLOROBENCIL)-3-HIDROXI-7,8,9,10-TETRAHIDROBENZO[h]QUINOLIN-4-CARBOXILICO, QUE CONSISTE EN HIDROLIZAR EN UN MEDIO ACIDO UN COMPUESTO (III), Y LUEGO ACOPLAR EN UN MEDIO QUE COMPRENDE ALCOHOL Y UNA BASE, EL PRODUCTO OBTENIDO CON UN COMPUESTO (V) OBTENIENDOSE DE ESTA FORMA EL COMPUESTO VI. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA. ESTOS COMPUESTOS SON INHIBIDORES DE SELECTINA Y SON UTILES PARA EL TRATAMIENTO DE PROCESOS DE INFLAMACION Y ADHESION O ATEROSCLEROSIS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72373405P | 2005-10-05 | 2005-10-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20070590A1 true PE20070590A1 (es) | 2007-07-11 |
Family
ID=37672216
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2006001208A PE20070590A1 (es) | 2005-10-05 | 2006-10-04 | PROCESO PARA LA SINTESIS DE COMPUESTOS 3-HIDROXI-7,8,9,10-TETRAHIDROBENZO[h]QUINOLIN-4-CARBOXILICO SUSTITUIDOS COMO INHIBIDORES DE SELECTINA |
Country Status (19)
Country | Link |
---|---|
US (1) | US20070082923A1 (es) |
EP (1) | EP1931638A1 (es) |
JP (1) | JP2009511488A (es) |
KR (1) | KR20080053389A (es) |
CN (1) | CN101277936A (es) |
AR (1) | AR058079A1 (es) |
AU (1) | AU2006302375A1 (es) |
BR (1) | BRPI0616906A2 (es) |
CA (1) | CA2624552A1 (es) |
CR (1) | CR9854A (es) |
EC (1) | ECSP088340A (es) |
GT (1) | GT200600447A (es) |
IL (1) | IL190435A0 (es) |
NO (1) | NO20081548L (es) |
PE (1) | PE20070590A1 (es) |
RU (1) | RU2008112191A (es) |
TW (1) | TW200738639A (es) |
WO (1) | WO2007044475A1 (es) |
ZA (1) | ZA200802990B (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20090127183A (ko) * | 2007-03-30 | 2009-12-09 | 와이어쓰 | 퀴놀린 유도체, 및 이를 포함하는 셀렉틴 억제용 제약 조성물 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6239280B1 (en) * | 1999-06-30 | 2001-05-29 | Merck & Co., Inc. | Process for synthesizing biaryl inhibitors of farnesyl-protein transferase |
PA8616901A1 (es) * | 2003-11-10 | 2005-05-24 | Wyeth Corp | Metodos y composiciones para la inhibicion de selectina |
-
2006
- 2006-10-04 PE PE2006001208A patent/PE20070590A1/es not_active Application Discontinuation
- 2006-10-04 TW TW095136879A patent/TW200738639A/zh unknown
- 2006-10-05 AR ARP060104394A patent/AR058079A1/es not_active Application Discontinuation
- 2006-10-05 RU RU2008112191/04A patent/RU2008112191A/ru not_active Application Discontinuation
- 2006-10-05 US US11/543,390 patent/US20070082923A1/en not_active Abandoned
- 2006-10-05 KR KR1020087009930A patent/KR20080053389A/ko not_active Application Discontinuation
- 2006-10-05 BR BRPI0616906-6A patent/BRPI0616906A2/pt not_active IP Right Cessation
- 2006-10-05 EP EP06825519A patent/EP1931638A1/en not_active Withdrawn
- 2006-10-05 WO PCT/US2006/039000 patent/WO2007044475A1/en active Application Filing
- 2006-10-05 GT GT200600447A patent/GT200600447A/es unknown
- 2006-10-05 CA CA002624552A patent/CA2624552A1/en not_active Abandoned
- 2006-10-05 CN CNA2006800369096A patent/CN101277936A/zh active Pending
- 2006-10-05 AU AU2006302375A patent/AU2006302375A1/en not_active Abandoned
- 2006-10-05 JP JP2008534685A patent/JP2009511488A/ja not_active Withdrawn
-
2008
- 2008-03-25 IL IL190435A patent/IL190435A0/en unknown
- 2008-03-31 NO NO20081548A patent/NO20081548L/no not_active Application Discontinuation
- 2008-04-01 CR CR9854A patent/CR9854A/es not_active Application Discontinuation
- 2008-04-02 EC EC2008008340A patent/ECSP088340A/es unknown
- 2008-04-04 ZA ZA200802990A patent/ZA200802990B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
TW200738639A (en) | 2007-10-16 |
ZA200802990B (en) | 2008-12-31 |
BRPI0616906A2 (pt) | 2011-07-05 |
AR058079A1 (es) | 2008-01-23 |
NO20081548L (no) | 2008-04-28 |
CA2624552A1 (en) | 2007-04-19 |
WO2007044475A1 (en) | 2007-04-19 |
ECSP088340A (es) | 2008-06-30 |
CR9854A (es) | 2008-05-21 |
CN101277936A (zh) | 2008-10-01 |
AU2006302375A1 (en) | 2007-04-19 |
JP2009511488A (ja) | 2009-03-19 |
IL190435A0 (en) | 2008-11-03 |
EP1931638A1 (en) | 2008-06-18 |
GT200600447A (es) | 2007-05-08 |
US20070082923A1 (en) | 2007-04-12 |
KR20080053389A (ko) | 2008-06-12 |
RU2008112191A (ru) | 2009-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR055779A1 (es) | Proceso de preparacion de azoxistrobina y composicion que contiene al compuesto | |
PE20091834A1 (es) | Compuestos de 2-imino-3-metilpirrolopirimidinona tiofenilo-sustituida como inhibidores de bace-1 y composiciones que los contienen | |
HK1133257A1 (es) | ||
EA200970519A1 (ru) | Полиморфы сукцината 2-[6-(3-аминопиперидин-1-ил)-3-метил-2,4-диоксо-3,4-дигидро-2h-пиримидин-1-илметил]-4-фторбензонитрил и способы их применения | |
PE20070367A1 (es) | Compuestos de espiropiperidina como inhibidores de la enzima beta secretasa | |
TW200716511A (en) | New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it | |
CR10095A (es) | Derivados de pirimidina para el tratamiento del crecimiento celular anormal | |
MY140841A (en) | Indozolone derivatives as 11b-hsd1 inhibitors | |
PE20071061A1 (es) | Derivados de carbonilo como inhibidores de peptidil-deformilasa (pdf) | |
JO2926B1 (en) | Organic compounds | |
PE20061142A1 (es) | Forma cristalina gamma de clorhidrato de ivabradina, su procedimiento de preparacion y composiciones farmaceuticas que la contienen | |
PE20141534A1 (es) | Derivados de imidazol como inhibidores de la enzima pde10a | |
EA201170053A1 (ru) | Способ получения и сушки твердого разагилина в форме основания | |
BRPI0612475B8 (pt) | métodos para a preparação de um composto | |
WO2007083090A3 (en) | Process for the preparation of uracil derivatives | |
MX2010003849A (es) | Antagonistas de cgrp. | |
PT2049480E (pt) | Derivados de 2-arilindole como inibidores da mpges-i | |
MX2012003615A (es) | Composiciones de limpieza abrasivas, acidas, viscosas. | |
ECSP088525A (es) | Proceso para la preparación de aminas | |
TW200635905A (en) | Processes for producing 4-aminoquinazolines | |
WO2007074475A3 (en) | Novel polymorphic forms of ibandronate | |
EP1512738A4 (en) | PROCESS RELATING TO THE PRODUCTION OF FATTY ACID ALKYL ESTER COMPOSITION | |
ATE447567T1 (de) | Verfahren zur herstellung von tryptase- inhibitoren | |
WO2009140101A3 (en) | Imidazopyridine compounds useful as mmp-13 inhibitors | |
CO5700712A2 (es) | Prevencion y tratamiento de la enfermedad de alzheimer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |